Athersys stem cells still show potential – Crain’s Cleveland Business
|
Athersys stem cells still show potential
Crain’s Cleveland Business There, regulators have eased restrictions on stem cell therapies that have proven to be safe, and MultiStem hasn’t shown any safety issues. Plus, Athersys already has an ally in Japan who could help fund such a study: It struck a licensing agreement … |
2 Minute Medicine |
Autologous stem–cell transplantation may be safe without transfusion support
2 Minute Medicine 1. In a prospective cohort study of over 120 Jehovah’s Witnesses with lymphoma and multiple myeloma, high-dose chemotherapy (HDC), and autologous stem–cell transplantation (ASCT) without transfusion support was associated with relatively low mortality … |
2 Minute Medicine |
Autologous stem–cell transplantation may be safe without transfusion support
2 Minute Medicine 1. In a prospective cohort study of over 120 Jehovah’s Witnesses with lymphoma and multiple myeloma, high-dose chemotherapy (HDC), and autologous stem–cell transplantation (ASCT) without transfusion support was associated with relatively low mortality … |
|
Some stem cells heal differently, researchers said
The Augusta Chronicle Forget the traditional view that certain stem cells will heal by becoming replacement cells for damaged tissue. The real power of these cells comes from their ability to regulate the immune response and spark the body’s own regenerative machinery … |
|
Some stem cells heal differently, researchers said
The Augusta Chronicle Forget the traditional view that certain stem cells will heal by becoming replacement cells for damaged tissue. The real power of these cells comes from their ability to regulate the immune response and spark the body’s own regenerative machinery … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |